Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial
Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial
Recruiting · NCT06919380 · Registry updated 2025-04-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial | interstitial lung disease, lung disorder, respiratory system disorder | Recruiting | Phase 1 | 2025-04-10 | NCT06919380 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Li Shiyue | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou | China | 1 |